Victor Wang

Writesonic is revolutionizing the landscape of content creation and customer experience, serving as your reliable companion in crafting captivating content and developing powerful AI Agents. Our platform combines the power of AI and creativity to provide a comprehensive suite of tools for Content Creation, Audio Generation, and Image Crafting. We empower everyone to write anything, publish anywhere, and optimize their content with unparalleled ease. Our robust AI Agent builder, Botsonic, seamlessly integrates with platforms such as Slack, WhatsApp, Telegram, and FB Messenger, ensuring uninterrupted omnichannel conversations. It also offers a Human Hand-off feature, facilitating smooth transitions from bot to human interactions. With our Zapier integration, we automate tasks and streamline workflows, enhancing customer engagement. Botsonic is GDPR-compliant, promising secure customer interactions. Together, our suite of tools aims to redefine content generation and customer experience, making Writesonic your one-stop solution for all your digital needs. Our customers love us, as evidenced by the 5000+ 5-star reviews on G2, TrustPilot, and Capterra. Backed by Y Combinator, HOF Capital (investors in Uber, Stripe, Alibaba, UiPath, Klarna), Rebel Fund (team includes founders of Instacart, Reddit, and Cruise), Soma Capital (investors in Deel, Rippling, Razorpay, Lattice, coda, Rappi), Broom Ventures, Amino Capital (investors in Zoom, Webflow, Rippling) and some of the best angels from different industries.

Kraken helps people own the power of their money. Founded in 2011, were one of the worlds longest-standing crypto platforms, now offering crypto, stocks, futures, staking, payments and more. Trusted by millions of institutions, professional traders, and consumers across 190+ countries. Built on the belief that everyone should own the power of their money, Kraken has been a category leader in crypto since 2011. Weve grown into a global financial platform offering crypto, stocks, futures, staking, payments and institutional infrastructure — all on a single foundation built for the future of finance. Our product lineup: — Kraken: the worlds leading hybrid investment platform, built for the future of finance from the ground up — Kraken Pro: the all-in command center that unleashes your trading potential — Krak: the next-generation money platform that turns every type of asset into usable money Proof of Reserves since 2014. Assets held 1:1. Trusted by 13M+ people, thousands of institutions, and a growing community of developers building on Kraken rails. Our mission: accelerate the global adoption of crypto so everyone can achieve financial freedom and inclusion. Risk Disclosure: https://www.kraken.com/en-ca/social-media-disclosure

21.co is the world’s leader in providing access to crypto through simple and easy to use products. 21.co is the parent company of 21Shares, the world’s largest issuer of cryptocurrency exchange traded products (ETPs) – which is powered by Onyx, a proprietary technology platform used to issue and operate cryptocurrency ETPs for 21Shares and third parties. The company was founded in 2018 by Hany Rashwan and Ophelia Snyder. 21.co is registered in Zug, Switzerland with offices in Zurich and New York. For more information, please visit www.21.co.

Republic is a financial technology firm specializing in private market investment services. Republic operates a marketplace platform for community finance, accredited investment opportunities, full-service tokenization, digital asset management, blockchain advisory, and private institutional capital. Republic has deployed over $2.6 billion in investments, supported over 2,500 ventures, with a community of over 3M users across 150 countries. Republic is backed by dozens of leading investment firms and financial institutions and has co-invested with the best names in venture and private equity. Founded in 2016, Republic is headquartered in New York City with offices worldwide. For additional information, visit republic.com or @joinrepublic on X. Worth building™

insitro is a data-driven drug discovery and development company that leverages machine learning and high-throughput biology to transform the way medicines are created to help patients. At insitro, we are rethinking the entire drug discovery process, from the perspective of machine learning, human genetics, and high-throughput, quantitative biology. Over the past five decades, we have seen the development of new medicines becoming increasingly more difficult and expensive, leaving many patients with significant unmet need. We’re embarking on a new approach to drug development – one that leverages machine learning and unique in vitro strategies for modeling disease state and designing new therapeutic interventions. We aim to eliminate key bottlenecks in traditional drug discovery, so we can help more people sooner and at a much lower cost to the patient and the healthcare industry. We believe that by harnessing the power of technology to interrogate and measure human biology, we can have a major impact on many diseases. We invest heavily in cutting edge bioengineering technologies to enable the construction of large-scale, high-quality data sets that are designed specifically to drive machine learning methods. Our first application is to use human genetics, functional genomics, and machine learning to build a new generation of in vitro human cell-derived disease models whose response to perturbation is designed to be predictive of human clinical outcomes. This cannot be done without great people. We are bringing together an outstanding team of people whose expertise spans multiple disciplines - life sciences, machine learning, human genetics, engineering, and drug discovery - and building a unique culture where people from diverse backgrounds work as a single team towards a common goal. We offer opportunities to collaborative people with expertise in life science and computational science. Join us to help bring better health to more people, faster and cheaper.

Helium Health is the largest provider of full-service technology solutions for all healthcare stakeholders in emerging markets. The foundation of which is our SaaS based electronic medical records/hospital management information system (EMR/HMIS). We are on a quest to improve global health efficiencies and outcomes using data and technology. Find out more at http://heliumhealth.com

Working on turning stem cells into human eggs

Machine Learning for Drug Discovery. PostEra is building a modern 21st century biopharma. We're using our advances in machine learning to accelerate Medicinal Chemistry and bring more cures to patients. PostEra advances small molecule programs through partnerships with biopharma while also advancing its own internal pipeline. We've raised $26M from top investors and closed $1Bn in AI partnerships, signing multi-year agreements with Amgen, Pfizer and the NIH. PostEra also launched and helped lead the world's largest open-science drug discovery effort; COVID Moonshot.

Con presencia en México y Colombia, habi ha llegado a ayudar en la evolución del ecosistema de bienes raíces a través de tecnología y análisis de datos. Brindamos al mercado simplicidad en los procesos y transacciones de forma segura y rápida. Los clientes habi pueden vender su casa en 10 días, comprar su nuevo hogar, conocer el valor aproximado de su inmueble y tener acompañamiento para la obtención de créditos hipotecarios. Las inmobiliarias aliadas pueden vendernos sus apartamentos y aumentar su portafolio de oferta con nuestros inmuebles. Los Brokers aliados pueden comisionar más rápido, ampliar su portafolio de inmuebles y tener acceso a herramientas tecnológicas y capacitaciones. Queremos empoderar a las familias latinoamericanas en la decisión financiera más importante de su vida y apoyar a nuestros aliados democratizando el acceso a la información con transparencia y confianza.

Metagenomi is a precision genetic medicines company committed to developing curative therapeutics for patients using our proprietary, comprehensive metagenomics-derived genome editing toolbox. We believe tools with capa­bil­i­ties that go beyond the cur­rent tech­nol­o­gy land­scape will be required in order to reach the full ther­a­peu­tic poten­tial of genome edit­ing. By har­ness­ing the pow­er of metage­nomics, the study of genomes recov­ered from uncul­ti­vat­ed organ­isms in the nat­ur­al envi­ron­ment, we are dis­cov­er­ing and devel­op­ing a suite of nov­el genome edit­ing tools with the poten­tial to make any desired ther­a­peu­tic gene edit, any­where in the human genome.

Metagenomi is a precision genetic medicines company committed to developing curative therapeutics for patients using our proprietary, comprehensive metagenomics-derived genome editing toolbox. We believe tools with capa­bil­i­ties that go beyond the cur­rent tech­nol­o­gy land­scape will be required in order to reach the full ther­a­peu­tic poten­tial of genome edit­ing. By har­ness­ing the pow­er of metage­nomics, the study of genomes recov­ered from uncul­ti­vat­ed organ­isms in the nat­ur­al envi­ron­ment, we are dis­cov­er­ing and devel­op­ing a suite of nov­el genome edit­ing tools with the poten­tial to make any desired ther­a­peu­tic gene edit, any­where in the human genome.

HeadSpins data science-driven platform helps businesses identify and fix issues that impact user experience, improve app performance, and enhance user engagement. With HeadSpins data science capabilities, businesses can stay ahead of the competition and meet their business goals.

BillionToOne is a precision diagnostics company with the mission to make molecular diagnostics more accurate, efficient, and accessible. Our proprietary molecular counting platform can accurately count DNA molecules at the single-count level to help improve disease detection.

StyleAI is the AI-powered, all-in-one unified marketing platform for businesses and ambitious marketing teams. Thousands of companies rely on Style to manage their SEO strategies, Google Ads campaigns, and websites in real time, with out-of-the-box, powerful automations.
 Based in San Francisco, StyleAI offers three turnkey products: Seona, Trenda, and Adwin, sitting upon a unified framework suited for all sizes of businesses and teams.
 Learn more at usestyle.ai

Writesonic is revolutionizing the landscape of content creation and customer experience, serving as your reliable companion in crafting captivating content and developing powerful AI Agents. Our platform combines the power of AI and creativity to provide a comprehensive suite of tools for Content Creation, Audio Generation, and Image Crafting. We empower everyone to write anything, publish anywhere, and optimize their content with unparalleled ease. Our robust AI Agent builder, Botsonic, seamlessly integrates with platforms such as Slack, WhatsApp, Telegram, and FB Messenger, ensuring uninterrupted omnichannel conversations. It also offers a Human Hand-off feature, facilitating smooth transitions from bot to human interactions. With our Zapier integration, we automate tasks and streamline workflows, enhancing customer engagement. Botsonic is GDPR-compliant, promising secure customer interactions. Together, our suite of tools aims to redefine content generation and customer experience, making Writesonic your one-stop solution for all your digital needs. Our customers love us, as evidenced by the 5000+ 5-star reviews on G2, TrustPilot, and Capterra. Backed by Y Combinator, HOF Capital (investors in Uber, Stripe, Alibaba, UiPath, Klarna), Rebel Fund (team includes founders of Instacart, Reddit, and Cruise), Soma Capital (investors in Deel, Rippling, Razorpay, Lattice, coda, Rappi), Broom Ventures, Amino Capital (investors in Zoom, Webflow, Rippling) and some of the best angels from different industries.

Kraken helps people own the power of their money. Founded in 2011, were one of the worlds longest-standing crypto platforms, now offering crypto, stocks, futures, staking, payments and more. Trusted by millions of institutions, professional traders, and consumers across 190+ countries. Built on the belief that everyone should own the power of their money, Kraken has been a category leader in crypto since 2011. Weve grown into a global financial platform offering crypto, stocks, futures, staking, payments and institutional infrastructure — all on a single foundation built for the future of finance. Our product lineup: — Kraken: the worlds leading hybrid investment platform, built for the future of finance from the ground up — Kraken Pro: the all-in command center that unleashes your trading potential — Krak: the next-generation money platform that turns every type of asset into usable money Proof of Reserves since 2014. Assets held 1:1. Trusted by 13M+ people, thousands of institutions, and a growing community of developers building on Kraken rails. Our mission: accelerate the global adoption of crypto so everyone can achieve financial freedom and inclusion. Risk Disclosure: https://www.kraken.com/en-ca/social-media-disclosure

21.co is the world’s leader in providing access to crypto through simple and easy to use products. 21.co is the parent company of 21Shares, the world’s largest issuer of cryptocurrency exchange traded products (ETPs) – which is powered by Onyx, a proprietary technology platform used to issue and operate cryptocurrency ETPs for 21Shares and third parties. The company was founded in 2018 by Hany Rashwan and Ophelia Snyder. 21.co is registered in Zug, Switzerland with offices in Zurich and New York. For more information, please visit www.21.co.